CANCER OF OVARY
Clinical trials for CANCER OF OVARY explained in plain language.
Never miss a new study
Get alerted when new CANCER OF OVARY trials appear
Sign up with your email to follow new studies for CANCER OF OVARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early cancer drug trial halted before key testing phase
Disease control TerminatedThis early-stage study tested a new oral cancer drug called NUV-868, both alone and combined with existing medications (olaparib or enzalutamide), in adults with advanced solid tumors. The trial aimed to find safe doses and see if these treatments could help control cancers that …
Matched conditions: CANCER OF OVARY
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Targeted cancer drug trial halted after testing in 19 patients
Disease control TerminatedThis study tested an experimental drug called Promitil for people with advanced ovarian or pancreatic cancer that had specific genetic mutations and had worsened after initial treatment. The trial aimed to see if this new formulation could better control cancer growth while being…
Matched conditions: CANCER OF OVARY
Phase: PHASE2 • Sponsor: Lipomedix Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC